PMC:7105881 / 55781-56097
Annnotations
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
1710 | 29-33 | Species | denotes | mice | Tax:10090 |
1711 | 41-49 | Species | denotes | MERS-CoV | Tax:1335626 |
1713 | 218-236 | Disease | denotes | MERS-CoV infection | MESH:D018352 |
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T320 | 191-199 | Body_part | denotes | antibody | http://purl.org/sig/ont/fma/fma62871 |
LitCovid_AGAC
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
p63268s31 | 164-190 | MPA | denotes | local mucosal neutralizing |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T271 | 227-236 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T651 | 39-40 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T652 | 71-73 | http://purl.obolibrary.org/obo/CLO_0052676 | denotes | Fc |
LitCovid-PD-GO-BP
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T112 | 125-150 | http://purl.obolibrary.org/obo/GO_0002456 | denotes | cellular immune responses |
T113 | 125-150 | http://purl.obolibrary.org/obo/GO_0002449 | denotes | cellular immune responses |
T114 | 125-150 | http://purl.obolibrary.org/obo/GO_0002443 | denotes | cellular immune responses |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T299 | 0-316 | Sentence | denotes | For example, immunization of mice with a MERS-CoV subunit vaccine (RBD-Fc) via the intranasal route induced higher levels of cellular immune responses and stronger local mucosal neutralizing antibody responses against MERS-CoV infection than those induced by the same vaccine via the S.C. pathway (Ma et al., 2014a). |
LitCovid-PMC-OGER-BB
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T918 | 29-33 | NCBITaxon:10088 | denotes | mice |
T919 | 41-49 | SP_9 | denotes | MERS-CoV |
T920 | 125-133 | GO:0051716 | denotes | cellular |
T921 | 134-140 | UBERON:0002405;GO:0006955 | denotes | immune |
T922 | 141-150 | GO:0006955 | denotes | responses |
T923 | 170-177 | UBERON:0000912 | denotes | mucosal |
T924 | 191-199 | GO:0042571;GO:0016064 | denotes | antibody |
T925 | 200-209 | GO:0016064 | denotes | responses |
T926 | 218-226 | SP_9 | denotes | MERS-CoV |
T39837 | 29-33 | NCBITaxon:10088 | denotes | mice |
T16700 | 41-49 | SP_9 | denotes | MERS-CoV |
T55053 | 125-133 | GO:0051716 | denotes | cellular |
T63741 | 134-140 | UBERON:0002405;GO:0006955 | denotes | immune |
T6035 | 141-150 | GO:0006955 | denotes | responses |
T53384 | 170-177 | UBERON:0000912 | denotes | mucosal |
T48624 | 191-199 | GO:0042571;GO:0016064 | denotes | antibody |
T90753 | 200-209 | GO:0016064 | denotes | responses |
T38294 | 218-226 | SP_9 | denotes | MERS-CoV |